# Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome

> **NCT00640276** · PHASE4 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 187 (actual)

## Conditions studied

- Hypercholesterolemia
- Metabolic Syndrome

## Interventions

- **DRUG:** pitavastatin
- **BEHAVIORAL:** Lifestyle Modification

## Key facts

- **NCT ID:** NCT00640276
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-02
- **Final completion:** 2011-06
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2012-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00640276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00640276, "Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00640276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*